US-Listed Pharmaceutical Preparations — EBITDA Margin Percentiles
Population: 131 US-listed companies (SIC 2834), most recent complete fiscal year per filer; fiscal year ends to .
| 10th percentile | -521.6% |
|---|
| 25th percentile | -139.1% |
|---|
| Median | -15.2% |
|---|
| 75th percentile | 9.8% |
|---|
| 90th percentile | 26.4% |
|---|
| Mean | — |
|---|
| Minimum | -970.1% |
|---|
| Maximum | 52.3% |
|---|
Methodology & sources
EBITDA margin = (operating income + depreciation & amortization) / revenue, all values as filed; computed in SQL per company, then percentiles.
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, as of .
Scope: {"source": "SEC EDGAR (XBRL, as-filed); Summe, Division, percentile_cont in Postgres", "ebitda_semantics": "EBITDA GERECHNET als oi + D&A — kein adjusted EBITDA"}
Evidence samples
Query this live via API/MCP (template peer_ebitda_margin_percentiles); terms: /nutzung. Cite as: FACTANKER, https://factanker.com/industries/sic-2834/ebitda-margin